Medtronic will acquire Intersect ENT for about $28.25 per share or $1.1 billion.

[cafead]

via Medtronic is looking to beef up its ear, nose, and throat portfolio with the proposed acquisition of Intersect ENT, for $28.25 per share or $1.1 billion. The deal is set to close toward the end of Medtronic’s current fiscal year.

article source